Article info

Download PDFPDF

Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy

Authors

  • Jing Shi Department of PharmacologyInstitute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College Beijing China PubMed articlesGoogle scholar articles
  • Chen Chen Department of PharmacologyInstitute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College Beijing China PubMed articlesGoogle scholar articles
  • Rui Ju Department of PharmacologyInstitute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College Beijing China PubMed articlesGoogle scholar articles
  • Qingzhu Wang Department of PharmacologyInstitute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College Beijing China PubMed articlesGoogle scholar articles
  • Juan Li Department of PharmacologyInstitute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College Beijing China PubMed articlesGoogle scholar articles
  • Lei Guo Department of PharmacologyInstitute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College Beijing China PubMed articlesGoogle scholar articles
  • Caiying Ye Department of PharmacologyInstitute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College Beijing China PubMed articlesGoogle scholar articles
  • Dechang Zhang Department of PharmacologyInstitute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College Beijing China PubMed articlesGoogle scholar articles
  1. a shijingstudy{at}163.com
  2. b sabxina{at}126.com
  3. c jurui1984{at}163.com
  4. d 18301451989{at}163.com
  5. e bpumc63{at}126.com
  6. f leiguo{at}ibms.cams.cn
  7. g caiyingye{at}126.com
  8. h zhangdechang45{at}vip.sina.cn
View Full Text

Citation

Shi J, Chen C, Ju R, et al
Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy

Publication history

  • Received May 4, 2019
  • Accepted August 30, 2019
  • First published September 11, 2019.
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.